| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| DHRS13 | TSPAN6 | ENSGGOP00000022088 | ENSGGOP00000009762 | Dehydrogenase/reductase 13. | Tetraspanin. | 0.470 |
| G3QMQ8_GORGO | LCP2 | ENSGGOP00000003802 | ENSGGOP00000006455 | Uncharacterized protein. | Lymphocyte cytosolic protein 2. | 0.660 |
| G3QMQ8_GORGO | PNMA1 | ENSGGOP00000003802 | ENSGGOP00000006024 | Uncharacterized protein. | PNMA family member 1. | 0.619 |
| G3QMQ8_GORGO | TP63 | ENSGGOP00000003802 | ENSGGOP00000041775 | Uncharacterized protein. | Tumor protein 63 (p63); Acts as a sequence specific DNA binding transcriptional activator or repressor. The isoforms contain a varying set of transactivation and auto-regulating transactivation inhibiting domains thus showing an isoform specific activity. May be required in conjunction with TP73/p73 for initiation of p53/TP53 dependent apoptosis in response to genotoxic insults and the presence of activated oncogenes. | 0.623 |
| G3QMQ8_GORGO | TSPAN6 | ENSGGOP00000003802 | ENSGGOP00000009762 | Uncharacterized protein. | Tetraspanin. | 0.502 |
| G3QMQ8_GORGO | ZFHX4 | ENSGGOP00000003802 | ENSGGOP00000022938 | Uncharacterized protein. | Zinc finger homeobox 4. | 0.573 |
| G3QU99_GORGO | PNMA1 | ENSGGOP00000006298 | ENSGGOP00000006024 | Zinc finger protein 730. | PNMA family member 1. | 0.475 |
| G3QU99_GORGO | TP63 | ENSGGOP00000006298 | ENSGGOP00000041775 | Zinc finger protein 730. | Tumor protein 63 (p63); Acts as a sequence specific DNA binding transcriptional activator or repressor. The isoforms contain a varying set of transactivation and auto-regulating transactivation inhibiting domains thus showing an isoform specific activity. May be required in conjunction with TP73/p73 for initiation of p53/TP53 dependent apoptosis in response to genotoxic insults and the presence of activated oncogenes. | 0.482 |
| G3QU99_GORGO | TSPAN6 | ENSGGOP00000006298 | ENSGGOP00000009762 | Zinc finger protein 730. | Tetraspanin. | 0.462 |
| G3QU99_GORGO | ZFHX4 | ENSGGOP00000006298 | ENSGGOP00000022938 | Zinc finger protein 730. | Zinc finger homeobox 4. | 0.455 |
| LCP2 | G3QMQ8_GORGO | ENSGGOP00000006455 | ENSGGOP00000003802 | Lymphocyte cytosolic protein 2. | Uncharacterized protein. | 0.660 |
| LCP2 | PNMA1 | ENSGGOP00000006455 | ENSGGOP00000006024 | Lymphocyte cytosolic protein 2. | PNMA family member 1. | 0.609 |
| LCP2 | TP63 | ENSGGOP00000006455 | ENSGGOP00000041775 | Lymphocyte cytosolic protein 2. | Tumor protein 63 (p63); Acts as a sequence specific DNA binding transcriptional activator or repressor. The isoforms contain a varying set of transactivation and auto-regulating transactivation inhibiting domains thus showing an isoform specific activity. May be required in conjunction with TP73/p73 for initiation of p53/TP53 dependent apoptosis in response to genotoxic insults and the presence of activated oncogenes. | 0.586 |
| LCP2 | TSPAN6 | ENSGGOP00000006455 | ENSGGOP00000009762 | Lymphocyte cytosolic protein 2. | Tetraspanin. | 0.469 |
| LCP2 | ZFHX4 | ENSGGOP00000006455 | ENSGGOP00000022938 | Lymphocyte cytosolic protein 2. | Zinc finger homeobox 4. | 0.710 |
| PICK1 | TSPAN6 | ENSGGOP00000030069 | ENSGGOP00000009762 | Protein interacting with PRKCA 1. | Tetraspanin. | 0.569 |
| PNMA1 | G3QMQ8_GORGO | ENSGGOP00000006024 | ENSGGOP00000003802 | PNMA family member 1. | Uncharacterized protein. | 0.619 |
| PNMA1 | G3QU99_GORGO | ENSGGOP00000006024 | ENSGGOP00000006298 | PNMA family member 1. | Zinc finger protein 730. | 0.475 |
| PNMA1 | LCP2 | ENSGGOP00000006024 | ENSGGOP00000006455 | PNMA family member 1. | Lymphocyte cytosolic protein 2. | 0.609 |
| PNMA1 | TP63 | ENSGGOP00000006024 | ENSGGOP00000041775 | PNMA family member 1. | Tumor protein 63 (p63); Acts as a sequence specific DNA binding transcriptional activator or repressor. The isoforms contain a varying set of transactivation and auto-regulating transactivation inhibiting domains thus showing an isoform specific activity. May be required in conjunction with TP73/p73 for initiation of p53/TP53 dependent apoptosis in response to genotoxic insults and the presence of activated oncogenes. | 0.474 |
